Development of a new bombesin analog radiolabeled with lutetium-177: In vivo evaluation of the biological properties in Balb-C Mice

Cellular and Molecular Biology

Volumn 56, Issue 2, 2010, Pages 18-24

  Pujatti, P B ^a   Santos, J S ^a   Massicano, A V F ^a   Mengatti, J ^a   De Araujo, E B ^a  

^a INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

Author keywords

Biological properties; Bombesin analogs; Lutetium 177; Radiolabeling

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID PHENYLALANINE SPACER BOMBESIN LU 177; BOMBESIN DERIVATIVE; LUTETIUM 177; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG SYNTHESIS; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; RADIOCHEMISTRY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BOMBESIN; CHROMATOGRAPHY, THIN LAYER; GASTRIN-RELEASING PEPTIDE; LIGANDS; LUTETIUM; MALE; MICE; MICE, INBRED BALB C; PEPTIDES; RADIOISOTOPES; RADIOPHARMACEUTICALS; TEMPERATURE; TIME FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

AMPHIBIA; MUS;

EID: 79959543627     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T889     Document Type: Article

References (24)

1. Breeman, W.A.P., Hofland, L.J., de Jong, M., Bernard, B.F., Sinivasan, A., Kwekkeboom, D.J., Visser, T.J. and Kreening, E.P., Evaluation of radiolabeled bombesin analogues for receptor-targeted tumor imaging. Int. J. Cancer 1999, 81(4): 658-665.
2. 99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor positive tumors. Q. J. Nucl. Med. Mol. Imaging 2007, 51: 42-50.
3. Haley, T.J., Komesu, N., Efrus, M., Koste, L. and Uphan, H.C., Pharmacology and toxicology of lutetium chloride. J. Pharm. Sci. 1964, 53: 1186-1188.
4. 0]octreotide in patients. Eur. J. Nucl. Med. 2001, 28: 1319-1325.
5. 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. J. Nucl. Med. 2006, 47(7): 1144-52.
6. Maina, T., Nock, B.A., Zhang, H., Nikolopulou, A., Waser, B., Reubi, J.C. and Maecke, H.R., Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs. J. Nucl. Med. 2005, 46: 823-830.
7. 177Lu of specific activity and purity suitable for medical applications. J. Radioanal. Nucl. Chem. 2003, 257(1): 53-57.
8. Moody, T.W., Crawley, J.N. and Jensen, R.T., Pharmacology and neurochemistry of bombesin-like peptides. Peptides 1982, 3(3): 559-563.
9. Panigone, S. and Nunn, A.D., Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy. Q. J. Nucl. Med. Mol. Imaging 2006, 50: 310-321.
10. 2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues. PNAS 2007, 104(30): 12462-12467.
11. 64Cu-Labeled bombesin analogue. Bioconjugate Chem. 2003, 14: 756-763.
12. 3. Cancer Res. 2003, 63: 4082-4088.
13. Stangelberger, A., Schally, A.V., Varga, J.L., Zarandi, M., Szepeshazi, K., Armatis, P. and Halmos, G., Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous invasiveness of PC-3 human prostate cancer in Nude mice. Clin. Cancer Res. 2005, 11: 49-57.
14. Varvarigou, A.D., Bouziotis, P., Zikos, Ch., Scopinaro, F. and de Vicentis, G., Gastrin-releasing peptide (GRP) analogues for cancer imaging. Cancer Biother. Radiopharm. 2004, 19(2): 219-229.
15. 177Lu-AMBA. Eur. J. Nucl. Med. Mol. Imaging 2007, 34(1): 95-100.
16. Zhang, H., Chen, J., Waldherr, C., Hinni, K., Waser, B., Reubi, J.C. and Maecke, H.R., Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors. Cancer Res. 2004, 64: 6707-6715.
17. Correia, M. B. L., Magnata, S. S. L. P., Silva, I. M. S., Catanho, M. T. J. A. and Lima, F. F. Biokinetics and dosimetric studies about 99MTC(V)-DMSA distribution. Cell. Mol. Biol., 2010, 56 (2): 1-5.
18. Couto, R. M., De Barboza, M. F., De Souza, A. A., Muramoto, E., Mengatti, J. and De Araújo, E. B. In vivo comparative study of hydroxyapatite labeled with different radioisotopes: evaluation of the scintigraphic images. Cell. Mol. Biol., 2010, 56 (2): 6-11.
19. De Araújo, E. B., Pujatti, P. B. and Mengatti, J. Radiolabeling of substance p with lutetium-177 and biodistribution study in rat pancreatic tumor xenografted nude mice. Cell. Mol. Biol., 2010, 56 (2): 12-17.
20. Yano, V. F. and Lima, F. F. Radiation exposure from diagnostic nuclear medicine in alagoas (Brazil) in 2002-2005. Cell. Mol. Biol., 2010, 56 (2): 25-30.
21. Melo, I.B., Ueda, L.T., Araujo, E.B., Muramoto, E., Barboz, M.F., Mengatti, J., Buchpiguel, C.A. and Silva, C.P.G. Tecnetium-99m as alternative to produce somatostatin-labeled derivatives: comparative biodistribution evaluation with 111in-dtpa-octreotide. Cell. Mol. Biol., 2010, 56 (2): 31-36.
22. Silva, I C. O. A., Lucena, E. A., Souza, W. O., Dantas, A. L. A. and Dantas, B. M. Estimation of internal exposure to 99mo in nuclear medicine patients. Cell. Mol. Biol., 2010, 56 (2): 37-40.
23. Velasques De Oliveira, S. M., Julião, L. M. Q. C., Sousa, W. O., Mesquita, S. A. and Santos, M. S. Methodology for radionuclides quantification through "in vitro" bioassay. Cell. Mol. Biol., 2010, 56 (2): 31-43.
24. Velasques De Oliveira, S. M., Carlos, M. T., Carneiro, M. P., Da Silva, J. W. E., Kasai, E. P., Oliveira, A. R. N. and Boasquevisque, E. M. Protocol for 18F-FDG quantification in PET-CT whole-body exams. Cell. Mol. Biol., 2010, 56 (2): 44-46.